• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大建中汤(TJ-100)围手术期给药可减少胰十二指肠切除术患者术后的麻痹性肠梗阻。

Perioperative administration of Daikenchuto (TJ-100) reduces the postoperative paralytic ileus in patients with pancreaticoduodenectomy.

作者信息

Okada Ken-Ichi, Kawai Manabu, Hirono Seiko, Miyazawa Motoki, Shimizu Atsushi, Kitahata Yuji, Yamaue Hiroki

出版信息

Hepatogastroenterology. 2015 Mar-Apr;62(138):466-71.

PMID:25916084
Abstract

BACKGROUND/AIMS: No study has reported whether perioperative administration of Daikenchuto (TJ-100) reduced paralytic ileus after pancreaticoduodenectomy (PD).

METHODOLOGY

Forty-five consecutive patients that were scheduled to undergo PD at Wakayama Medical University Hospital between August 2010 and August 2011 were enrolled in this study including the first cohort (n = 15) as the control group and the subsequent cohort (n = 30) as the TJ-100 group. This trial was registered at UMIN-CTR ID# 000005056.

RESULTS

Postoperative paralytic ileus occurred more frequently in the control group (73.3% of the control group and 20.0% of the TJ-100 group; p = 0.001). The first passages of flatus significantly improved earlier in the TJ-100 group than in the control group (p = 0.014). A multiple cytokine assay of the drainage and serum showed that IL-9 and IL-10 in the drainage was significantly higher on postoperative day 1 in the TJ-100 group. There were no complications associated with the preoperative administration of TJ-100 before surgery, and no significant differences were observed between the two groups in the incidence of postoperative Gradel-2 diarrhea (CTCAE4.0).

CONCLUSIONS

Perioperative administration of TJ-100 was feasible and reduced the incidence of paralytic ileus in PD, and further randomized controlled trials should be conducted.

摘要

背景/目的:尚无研究报道围手术期给予大建中汤(TJ - 100)能否减少胰十二指肠切除术(PD)后发生的麻痹性肠梗阻。

方法

选取2010年8月至2011年8月期间在和歌山县医科大学医院计划接受PD的45例连续患者纳入本研究,其中第一组(n = 15)作为对照组,后续组(n = 30)作为TJ - 100组。本试验在UMIN - CTR注册号为000005056。

结果

对照组术后麻痹性肠梗阻的发生率更高(对照组为73.3%,TJ - 100组为20.0%;p = 0.001)。TJ - 100组首次排气明显早于对照组(p = 0.014)。对引流液和血清进行的多种细胞因子检测显示,TJ - 100组术后第1天引流液中的IL - 9和IL - 10显著更高。术前给予TJ - 100未出现与手术相关的并发症,两组术后2级腹泻(CTCAE4.0)的发生率无显著差异。

结论

围手术期给予TJ - 100是可行的,且可降低PD后麻痹性肠梗阻的发生率,应进一步开展随机对照试验。

相似文献

1
Perioperative administration of Daikenchuto (TJ-100) reduces the postoperative paralytic ileus in patients with pancreaticoduodenectomy.大建中汤(TJ-100)围手术期给药可减少胰十二指肠切除术患者术后的麻痹性肠梗阻。
Hepatogastroenterology. 2015 Mar-Apr;62(138):466-71.
2
Evaluation of the efficacy of daikenchuto (TJ -100) for the prevention of paralytic ileus after pancreaticoduodenectomy: A multicenter, double-blind, randomized, placebo-controlled trial.大建中汤(TJ -100)预防胰十二指肠切除术后麻痹性肠梗阻疗效的评估:一项多中心、双盲、随机、安慰剂对照试验。
Surgery. 2016 May;159(5):1333-41. doi: 10.1016/j.surg.2015.11.019. Epub 2015 Dec 31.
3
Effect of Daikenchuto (TJ-100) on postoperative bowel motility and on prevention of paralytic ileus after pancreaticoduodenectomy: a multicenter, randomized, placebo-controlled phase II trial (the JAPAN-PD study).大建中汤(TJ-100)对胰十二指肠切除术后肠动力的影响及术后麻痹性肠梗阻的预防:一项多中心、随机、安慰剂对照的 II 期临床试验(JAPAN-PD 研究)。
Jpn J Clin Oncol. 2013 Apr;43(4):436-8. doi: 10.1093/jjco/hyt005. Epub 2013 Jan 30.
4
Effect of Daikenchuto (TJ-100) on gastrointestinal symptoms following laparoscopic colectomy in patients with colon cancer: study protocol for a randomized controlled trial.大建中汤(TJ-100)对结肠癌腹腔镜结肠切除术后胃肠道症状的影响:一项随机对照试验的研究方案。
Trials. 2017 Nov 21;18(1):553. doi: 10.1186/s13063-017-2307-7.
5
The effects of the herbal medicine Daikenchuto (TJ-100) after esophageal cancer resection, open-label, randomized controlled trial.大建中汤(TJ-100)对食管癌切除术后影响的开放标签随机对照试验。
Esophagus. 2018 Apr;15(2):75-82. doi: 10.1007/s10388-017-0601-9. Epub 2017 Dec 20.
6
Clinical pharmacology of daikenchuto assessed by transit analysis using radiopaque markers in patients with colon cancer undergoing open surgery: a multicenter double-blind randomized placebo-controlled study (JFMC39-0902 additional study).使用不透射线标记物的转运分析评估大建中汤对接受开放手术的结肠癌患者的临床药理学:一项多中心双盲随机安慰剂对照研究(JFMC39 - 0902附加研究)
J Gastroenterol. 2016 Mar;51(3):222-9. doi: 10.1007/s00535-015-1100-1. Epub 2015 Jul 11.
7
Transcutaneous electrical acupoint stimulation applied in lower limbs decreases the incidence of paralytic ileus after colorectal surgery: A multicenter randomized controlled trial.经皮穴位电刺激应用于下肢可降低结直肠手术后麻痹性肠梗阻的发生率:一项多中心随机对照试验。
Surgery. 2021 Dec;170(6):1618-1626. doi: 10.1016/j.surg.2021.08.007. Epub 2021 Sep 6.
8
No Significant Effect of Daikenchuto (TJ-100) on Peritoneal IL-9 and IFN-γ Levels After Pancreaticoduodenectomy.大建中汤(TJ - 100)对胰十二指肠切除术后腹膜白细胞介素 - 9和干扰素 - γ水平无显著影响。
Clin Exp Gastroenterol. 2020 Oct 19;13:461-466. doi: 10.2147/CEG.S262082. eCollection 2020.
9
Randomized, placebo-controlled study of the efficacy of preoperative somatostatin administration in the prevention of postoperative complications following pancreaticoduodenectomy.术前给予生长抑素预防胰十二指肠切除术后并发症疗效的随机、安慰剂对照研究
Hepatogastroenterology. 2013 May;60(123):400-5. doi: 10.5754/hge12669.
10
Multicentre, randomised, placebo-controlled trial of extract of Japanese herbal medicine Daikenchuto to prevent bowel dysfunction after adult liver transplantation (DKB 14 Study).日本草药大建中汤提取物预防成人肝移植后肠功能障碍的多中心、随机、安慰剂对照试验(DKB 14研究)
BMJ Open. 2015 Sep 29;5(9):e008356. doi: 10.1136/bmjopen-2015-008356.

引用本文的文献

1
Research on Mechanisms of Chinese Medicines in Prevention and Treatment of Postoperative Adhesion.中药防治术后粘连的机制研究。
Chin J Integr Med. 2023 Jun;29(6):556-565. doi: 10.1007/s11655-023-3735-0. Epub 2023 Apr 13.
2
No Significant Effect of Daikenchuto (TJ-100) on Peritoneal IL-9 and IFN-γ Levels After Pancreaticoduodenectomy.大建中汤(TJ - 100)对胰十二指肠切除术后腹膜白细胞介素 - 9和干扰素 - γ水平无显著影响。
Clin Exp Gastroenterol. 2020 Oct 19;13:461-466. doi: 10.2147/CEG.S262082. eCollection 2020.
3
Transition of serum cytokines following pancreaticoduodenectomy: A subsidiary study of JAPAN-PD.
胰十二指肠切除术后血清细胞因子的变化:日本胰十二指肠切除术(JAPAN-PD)的一项附属研究
Oncol Lett. 2018 Nov;16(5):6847-6853. doi: 10.3892/ol.2018.9422. Epub 2018 Sep 7.
4
Time-, Sex-, and Dose-Dependent Alterations of the Gut Microbiota by Consumption of Dietary Daikenchuto (TU-100).食用大建中汤(TU - 100)对肠道微生物群的时间、性别和剂量依赖性改变。
Evid Based Complement Alternat Med. 2018 Feb 22;2018:7415975. doi: 10.1155/2018/7415975. eCollection 2018.
5
Acceleration of small bowel motility after oral administration of dai-kenchu-to (TJ-100) assessed by cine magnetic resonance imaging.通过电影磁共振成像评估口服大建中汤(TJ - 100)后小肠运动的加速情况。
PLoS One. 2018 Jan 10;13(1):e0191044. doi: 10.1371/journal.pone.0191044. eCollection 2018.
6
Complementary and synergistic therapeutic effects of compounds found in Kampo medicine: analysis of daikenchuto.汉方医学中化合物的互补和协同治疗作用:大建中汤分析
Front Pharmacol. 2015 Aug 4;6:159. doi: 10.3389/fphar.2015.00159. eCollection 2015.